Val-Cit-PAB-DEA-Dxd

SKU: orb2564824

Description

Val-Cit-PAB-DEA-Dxd (compound 81) is a cleavable drug-linker conjugate designed for constructing antibody-drug conjugates (ADCs). It incorporates the topoisomerase I inhibitor Dxd, enabling targeted cytotoxicity. This reagent is widely used in ADC research and development for both in vitro and in vivo preclinical studies.

Images & Validation

−

Key Properties

−

CAS Number	2964543-53-9
MW	1013.08
Formula	C₅₀H₆₁FN₁₀O₁₂
SMILES	N(C(COC(N(CCN(C(OCC1=CC=C(NC([C@@H](NC([C@H](C(C)C)N)=O)CCCNC(N)=O)=O)C=C1)=O)C)C)=O)=O)[C@@H]2C3=C4C(C=5N(C4)C(=O)C6=C(C5)[C@](CC)(O)C(=O)OC6)=NC=7C3=C(CC2)C(C)=C(F)C7
Target	Drug-Linker Conjugates for ADC

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

171364512 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols